CRFTF is an interesting stock at a crossroads. Its recent announcement of its acquisition of Ava Pathways puts it into the explosive psilocybin market space. But shares have yet to react. However, we are seeing possible signs of accumulation as volume grows.
A break above confluence MA's in the dime area would be big.
